Promising Mid Cap Stocks To Consider – November 17th

Light & Wonder, ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Metsera, AltC Acquisition, Cidara Therapeutics, and Opendoor Technologies are the seven Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of publicly traded companies with a medium market capitalization—commonly defined as roughly $2 billion to $10 billion, though exact cutoffs vary among indices and fund managers. For investors, mid caps typically offer a blend of growth potential and greater stability than small caps (but more volatility than large caps), making them useful for portfolio diversification and moderate-risk growth strategies. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.

Light & Wonder (LNW)

Light & Wonder, Inc. is a cross-platform global games company, which engages in the development of content and digital markets. It operates through the following segments: Gaming, SciPlay, and iGaming. The Gaming segment includes the design, manufacture, marketing, and distribution of portfolio of gaming products and services.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Direxion Daily TSLA Bull 2X Shares (TSLL)

Metsera (MTSR)

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

Cidara Therapeutics (CDTX)

Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates.

Opendoor Technologies (OPEN)

Opendoor Technologies Inc. operates a digital platform for residential real estate transactions in the United States. It buys and sells homes. The company's product offerings comprise sell to opendoor product that enables homeowners to sell their home directly to it and resell the home to a home buyer; list with opendoor product that allows customers to list their home on the MLS with opendoor and receive cash offer; and opendoor marketplace product that connects the home seller with an institutional or retail buyer.